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Objectives. To assess the long-term outcome of supervised exercise training for intermittent claudication.
Methods. A prospective study was undertaken of all patients referred to a single centre with intermittent claudication
(>46 m). Patients underwent supervised exercise training twice weekly for 10 weeks, with regular follow-up to 3 years.
Actual Claudication Distance (ACD), Maximum Walking Distance (MWD) and ankle-brachial pressure indices
(ABPI) were measured.
Results. In 202 patients the initial median ACD and MWD were 112 m and 197 m. Following exercise therapy both the
median ACD and MWD increased to 266 m and 477 m at three months, increases of 237% and 242% respectively
(p< 0.001). At three years the median ACD and MWD were 250 m and 372 m, increases of 223% and 188% respectively
(p< 0.001). There was no significant change in ACD or MWD at 3 months compared to 1, 2 or 3 years. ABPI remained
unchanged throughout.
Conclusions. Supervised exercise training has long term benefit in patients with intermittent claudication. Results seen at
12 weeks are sustained at three years.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Peripheral vascular disease (PVD) is common, affect-
ing 20% of people over 70 years, and is a manifestation
of systemic atherosclerosis. Symptoms of intermittent
claudication are present in 15e40% patients.1,2 Al-
though PVD causes disability and reduction in quality
of life, the natural history in the affected limb is rela-
tively benign. Only 25% patients show symptomatic
deterioration and approximately 2% progress to am-
putation.3 There is, however, a high associated cardio-
vascular risk, particularly of myocardial infarction and
stroke. 50% of claudicants die within 10 years, a rela-
tive risk of 3.8 compared with the normal population.4
Treatment of claudication is initially conservative
with control of risk factors and medical therapy. Exer-
cise as a treatment for intermittent claudication has
shown benefit in several small trials.5,6 Ameta-analysis
of randomised and non-randomised trials showed that
exercise programmes improve symptoms in patients
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onset of claudication pain and a 120% increase in max-
imum walking distance.5 The greatest improvement
occurred when patients exercised by walking to near-
maximal pain in sessions of greater than 30 minutes
each, at least three times a week, for more than six
months. A Cochrane review of randomised trials of
exercise for intermittent claudication had similar
findings with a 150% mean improvement in maximal
walking distance. They commented that data was pre-
dominantly from small trials with an average of 25 pa-
tients and short follow-up.7 Consequently concern
exists that the benefit seen from exercise training may
be temporary, as little long term follow up data exists.
The aim of this prospective study is to assess the long-
term efficacy of supervised exercise training for inter-
mittent claudication.
Methods
Patient recruitment
This study was undertaken at the vascular unit in
a large district general hospital, where three vascularn behalf of European Society for Vascular Surgery.
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tending the vascular service for whom intermittent
claudication was the main factor affecting mobility
were considered. Data was collected prospectively
on patients with intermittent claudication who had
been entered into a supervised exercise programme
from 1999e2004.
Inclusion criteria
The diagnosis of intermittent claudication was made
on the history, clinical examination and measurement
of ankle-brachial pressure indices (ABPI) before and
after exercise.8 All patients had a resting ABPI
< 0.9 and a positive response to a validated stress
test (a drop in ankle pressure of >30 mmHg following
2 minutes of treadmill walking at 10% incline and
3.2 km/h measured 40 sec post exercise9). If any
doubt existed a Duplex ultrasound scan was per-
formed. All patients had stable intermittent claudica-
tion for a minimum of 3 months and were able to
walk >300 m on the flat in 6 minutes.
After diagnosis risk factor modification and options
for treatment were discussed with each patient. The
normal protocol was that patients with mild to moder-
ate intermittent claudication (Fontaine Stage II3) were
referred for exercise therapy. Patients who wished to
have further investigationwith a view to interventional
treatment had an arterial Duplex scan carried out and
were offered angioplasty as appropriate. Patients who
were not suitable for angioplasty were referred for
exercise therapy. All patients who underwent exercise
therapy were included for analysis.
Exclusion criteria
All patients with severe claudication who were unable
to walk more than 46 metres (50 yards) were routinely
considered for further intervention by angioplasty or
reconstructive surgery and were excluded. In addition
the following patients were excluded: those who had
suffered a myocardial infarction, unstable angina or
cerebrovascular accident or undergone major surgery
in the previous three months, and patients with signif-
icant comorbidity preventing participation in an exer-
cise programme.
Outcome measures
A walk test was carried out to measure the Actual
Claudication Distance (ACD) and Maximum Walking
Distance (MWD). ACD was defined as the distance
walked until the patient experienced the onset of
muscle pain. MWD was defined as the maximum dis-
tance a patient could walk until they had to stop.At the start of the programme the ACD and MWD
were measured by the distance walked along a corri-
dor, following the purchase of a treadmill all walk
tests were and on a treadmill at a fixed speed
(3.2 km/h on the flat).
Exercise class
Supervised exercise training comprised of two classes
aweek, each lasting one hour, for tenweeks, supervised
by a vascular nurse specialist and senior physiothera-
pist. Each class started with undirected cycling on
a static bike for 5 minutes, followed by stretching exer-
cises as a warm-up. Formal exercises were then per-
formed, comprising of heel raises, step-ups and sit to
stand, each in repetitionsof ten.Patients exercised again
on the static bike (no set speed or resistance for
5e10 min) and walked on the treadmill (3.2 km/h for
up to 15 min). This was initially on the flat. Patients
were subsequently encouraged towalkonan increasing
incline up to amaximumof 10% as theirwalking ability
improved, this was individually tailored over time.
Patients were exercised to near maximal pain in
each exercise as determined by a visual analogue
pain scale, and then rested until pain-free before start-
ing the next one. Each patient kept an individual re-
cord of progress and perception of pain. As walking
ability improved the intensity of training was in-
creased for each individual by increasing the repeti-
tion of each exercise.
Whilst attending the programme patients were ad-
vised to exercise at home on the days that they were
not attending the classes and encouraged to take daily
walks, exercising beyond the onset of claudication.
After completing the programme all patients were fol-
lowed up by the vascular nurse specialist at 3, 6, 12, 24
and 36 months with a repeat walk test and ABPI. Each
patient’s consultant and general practitioner were in-
formed of progress by letter. Appropriate patients
were advised of the ‘Fit for the Future’ Programme in-
volving local leisure centres with reduced joining fees.
Some patients obtained sufficient benefit from su-
pervised exercise training that they were able to
walk more than ten minutes on the treadmill (to a total
distance of 570 m) without symptoms (see Table 1).
They were discharged from follow-up, essentially
pain-free. A distance of 570 m was recorded for anal-
ysis at this time point.
Endpoints
Primary endpoints for analysis were differences in
ACD, MWD and ABPI at 3, 6, 12, 24 and 36 months.
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intervention (angioplasty or surgery), death or dis-
charge for medical reasons. The data was analysed
using Instat 3 (www.graphpad.com).
Results
202 patients completed supervised exercise training.
Their average age was 68 years (range 40e89) and
151 (75%) were male. Patient risk factors included
smoking (47 current, 81 ex-smokers), hypertension
(93), high cholesterol (77) and diabetes (37). At initial
assessment the median ACD was 112 m (IQR 82e168)
and median MWD 197 m (IQR 47e357). Although the
walk test was initially performed by corridor walk
(n¼ 32, 16%) and subsequently by treadmill
(n¼ 170, 84%), there was no significant difference in
ACD or MWD as assessed by either method, either
at initial assessment (ACD p¼ 0.17, MWD p¼ 0.34)
or subsequent follow-up at any time point. The aver-
age ABPI at initial assessment was 0.64 (s.d. 0.18).
At three months following exercise therapy the
median ACD increased to 266 m (IQR 160e483,
p< 0.001) and the median MWD increased to 477 m
(IQR 280e570, p< 0.001), increases of 237% and
242% respectively. More than 90% of patients
benefited from exercise therapy with an individual in-
crease in their ACD and MWD (Table 2). At 6, 12, 24
and 36 months both ACD and MWD remained
Table 1. Outcome of patients undergoing supervised exercise ther-
apy for intermittent claudication at 3, 6, 12, 24 and 36 months
Outcome 3 6 12 24 36
Walk test 199 171 142 87 60
Discharged 1 2 10 21
Did not attend 3 4 5 0 2
Died 3 6 10 12
Operation 1 3 6 9
Outpatient appointment 3 3 3
Medically discharged 1 3 6 7
MIMIC Trial 1 1 3 3
Lost to follow-up 7 8 13 13
Total 202 189 173 138 130
Outcomes were: underwent walk test, discharged able to walk
without symptoms, failed to attend, died, underwent operation,
awaiting outpatient appointment to discuss treatment options,
discharged unable to exercise for medical reasons, enrolled in fur-
ther trial (MIMIC) and lost to follow-up.
Table 2. Benefit following exercise therapy at 3 and 36 months
3 months (n¼ 199) 36 months (n¼ 81)
ACD MWD ACD MWD
Benefit 185 (93%) 182 (91%) 77 (95%) 72 (89%)
Worse 14 (7%) 17 (9%) 4 (5%) 9 (11%)
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changed from 3 months (non-parametric ANOVA
p< 0.001, Figs. 1, 2). At 36 months the median ACD
was 250 m (IQR 152e446) and the median MWD
372 m (IQR 224e840), increases of 223% and 188% re-
spectively over values at the initial assessment. There
was no difference between results seen at 3, 6, 12, 24
and 36 months for ACD or MWD (non-parametric
ANOVA p< 0.001, with Dunn’s multiple comparison
test p> 0.05).
The mean resting ABPI remained unchanged
throughout the study at 0.64 at 3 months and 1 year,
and 0.61 at 3 years (N.S., Fig. 3).
At three years 130 patients were available for anal-
ysis, the remainder were still in follow up at different
time points. Sixty patients were still under annual re-
view and underwent a walk test. A further 21 had
been discharged, able to walk pain free more than
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Fig. 1. Actual Claudication distance (metres) at the start and
3, 6, 12, 24 and 36 months following exercise therapy. Data
are presented as medians and interquartile ranges.
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Fig. 2. Maximum Walking Distance (metres) at the start and
3, 6, 12, 24 and 36 months following exercise therapy. Data
are presented as medians and interquartile ranges.
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provement in their ACD and MWD (Table 2). Nine
(6.9%) had undergone vascular intervention (5 bypass
surgery, 4 angioplasty) with one (0.8%) amputation,
and twelve (9.2%) patients had died (5 ischaemic
heart disease, 2 carcinoma bronchus, 1 multiple he-
patic metastases, 1 cerebrovascular accident, 3 cause
unknown). Seven were medically discharged unable
to continue walking for other reasons (4 with cardiac
problems and one each with bronchiectasis, carci-
noma of stomach and stroke). The outcome of patients
at each time point is listed in Table 1.
Discussion
The results of this study add strong support to the
evidence that supervised exercise is of symptomatic
benefit for intermittent claudication.
A meta-analysis showed that the greatest improve-
ment occurred when patients exercised at least three
times a week for more than six months,5 compared
with twice a week for 10 weeks in this study. Our ex-
ercise programme started in 1998, at a time when few
exercise programmes were in existence in the UK and
none of these to our knowledge had a frequency of
three times per week. The frequency of twice weekly
classes was chosen and based on the successful results
obtained with this approach by the Oxford group.6,10
It was also found to be practical and well accepted
by patients.
All patients in this study were also advised to exer-
cise at home on the days that they were not attending
the classes and encouraged to take daily walks, exercis-
ing beyond the onset of claudication. After completion
of the exercise programme a vascular nurse specialist
followed up all patients annually. Although we did
not document the exercise regimens of individual pa-
tients during followup,many patients reported having
a set walk they undertook daily or having bought an
exercise bike or treadmill. Many patients regarded
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Fig. 3. Resting Ankle-Brachial Pressure Index (ABPI) after
recruitment into supervised exercise programme. Data are
presented as means and standard deviations.the annual follow up appointment as a challenge. The
role of continued support and encouragement at follow
up are likely to be important contributory factors to
these results.
At the start of the study 24% patients were
smokers, and all patients were encouraged to stop
smoking completely if possible. Unfortunately we
did not collect data on the effect of smoking cessation
and walking distance, partly because this would have
involved additional measurement of smoke markers11
and this would have further complicated the study.
However these results would still show a significant
benefit from exercise therapy, even if all 47 smokers
had stopped smoking completely, which is most
unlikely.
After the initial dramatic in walking ability at
3 months up to 1 year there was no further significant
improvement at 2 and 3 years, but the increase was
sustained. At 3 years patients were able to walk twice
as far on average before their claudication pain devel-
oped, and also before they had to stop walking. This is
in contrast to other studies in which walking ability
reduced and a partial loss of training effect occurred,
after initial improvement.12
In the Cochrane review, 10 trials and a total of al-
most 250 patients were analysed.7 These were all small
(25e49) patients and follow-up ranged from 12 weeks
to 15 months. There was some variation in the exercise
regimens used, although all recommended at least two
weekly sessions of mostly supervised exercise. It was
concluded that a thrice-weekly regimen of walking
to near-maximal pain provides the best improvement.
The data presented here show that improvement in
walking ability was obtained in twice weekly sessions.
Our exercise therapy was supervised for 10 weeks and
suggests that there may be no need for longer courses
of more than 6 months, as has been suggested.5
It is clear that the previous standard advice of a
decade and more ago to ‘‘stop smoking and keep
walking’’13 should be replaced by a structured and
coordinated plan of care involving routine access to
supervised exercise programmes. These should be
made available to all affected patients. In these data
we did not assess quality of life before and after exer-
cise therapy. Cheetham found that supervised exer-
cise provides a significant improvement in patients’
symptoms and quality of life compared with advice
alone,14 and there is little evidence that exercise
advice alone is effective treatment.15
The mechanisms behind the improvement in walk-
ing ability are multifactorial and include a redistribu-
tion of blood flow, changes in oxidative capacity of the
skeletal muscles and greater utilisiation of oxygen, to-
gether with improved blood rheology and decreased
Eur J Vasc Endovasc Surg Vol 34, September 2007
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fusion injury.16e18 The relative importance of these
factors is uncertain, but it is clear that the response
to supervised exercise training occurs quickly with
a maximal effect at 3 months from commencement.
We should now be able to give this positive message
to patients with intermittent claudication. Not only
should affected patients expect to be entered into a su-
pervised exercise programme, they can also expect
a rapid and marked improvement in their symptoms
with this safe and simple therapy and changes to their
life style, with lasting benefit.
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